Trends in MRSA-associated Pneumonia and Septicemias, 2010-2014

  30 September 2019

CDDEP researchers calculated rates of Staphylococcus aureus and MRSA-related hospitalizations from 2010 to 2014, for septicemias, pneumonias, and unspecified S. aureus infections, using inpatient records from the National Inpatient Survey (NIS) from the Healthcare Cost and Utilization Project of the Agency for Health Research and Quality (AHRQ). The researchers found that while hospitalization rates for MRSA-

related skin and soft-tissue infections (SSTIs) decreased between 2010 and 2014, rates for more invasive MRSA-related infections, such as sepsis and pneumonia, remained constant. The rate of MRSA septicemias increased from 1.45 to 1.53 per 1,000 hospitalizations and MRSA pneumonia fluctuated between 1.54 to 1.38 per 1,000 hospitalizations.

Further reading: CDDEP
Author(s): CDDEP
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Global Ambassador Network

Welcome at the AMR Insights Ambassador Network!

The AMR Insights Ambassador Network is a growing, distinctive group of professionals who stand out for their commitment, willingness to cooperate and open attitude to combat Antimicrobial resistance (AMR).

More information and free-of-charge registration
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!